Case Control Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 26, 2024; 12(18): 3321-3331
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3321
Table 5 Occurrence of adverse reactions amongst the three groups [n (%)]
Group
n
Dizziness
Nausea/vomiting
Rash
Abdominal pain/diarrhoea
Hypertension
Tinnitus
Fever
Occurrence rate
A4110000102 (4.88)b
B3522111119 (2.57)a,c
C3300000101 (3.03)b
χ2--------11.443
P value--------0.003